Role of Mast Cells, Basophils and Their Mediators in Adverse Reactions to General Anesthetics and Radiocontrast Media

International Archives of Allergy and Immunology

Volumn 110, Issue 1, 1996, Pages 13-22

  Genovese, Arturo ^a   Stellato, Cristiana ^a   Marsella, Carlo Vincenzo ^a   Adt, Monika ^b   Gianni, Marone ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Anesthetics; Basophils; Contrast media; Histamine; Mast cells; Tryptase

Indexed keywords

ALTHESIN; ANESTHETIC AGENT; ATRACURIUM; BARBITURIC ACID DERIVATIVE; BUPRENORPHINE; CONTRAST MEDIUM; DEXTRAN; FENTANYL; HISTAMINE; ICOSANOID; IOVERSOL; LEUKOTRIENE C4; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; MEGLUMINE IOXITALAMATE PLUS SODIUM IOXITALAMATE; METHOHEXITAL; MORPHINE; PANCURONIUM; POLYGELINE; PROPANIDID; PROPOFOL; PROSTAGLANDIN D2; PROTAMINE; SUXAMETHONIUM; THIOPENTAL; THROMBOCYTE ACTIVATING FACTOR; TRYPTASE; TUBOCURARINE CHLORIDE; VASOACTIVE AGENT; VECURONIUM;

ANAPHYLAXIS; BASOPHIL; BRADYCARDIA; BRONCHOSPASM; EDEMA; HALF LIFE TIME; HEART; HEART ARRHYTHMIA; HISTAMINE RELEASE; HUMAN; HYPEROSMOLALITY; HYPOTENSION; INCIDENCE; LUNG; LUNG EDEMA; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL; RASH; REVIEW; SKIN; TACHYCARDIA; URTICARIA; VASCULAR DISEASE;

EID: 0029926394     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237305     Document Type: Article

References (102)

1. Beaven MA: Anaphylactoid reactions to anesthetic drugs. Anesthesiology 1981:55:3 5.
2. Doenicke A. Ennis M. Lorenz W: Histamine release in anesthesia and surgery: A systematic approach to risk in the perioperative period. Int Anesthesiol Clin 1985:23:41 66.
3. Laxenaire MC, Moneret-Vautrin DA. Vervloët D, Alazia M. François G: Accidents anaphilac-toi'des graves pcriancsthcsiqucs. Ann Fr Anesth Réanim 1985;4:30-46.
4. Moss J, Fahrny NR, Sunder N, Bcavcn MA: Hormonal and hemodynamic profile of an anaphylactic reaction in man. Circulation 1981:63: 210 213.
5. Assetti E-SK: Anaphylactic anaesthetic reactions. Anaesthesia 1990:45:1032 1038.
6. Binkley K, Checma A. Sussman D, Moudgil G, O'Connor M. Evans S, Dolovich J: Generalized allergie reactions during anesthesia. J Allergy Clin Immunol 1992;89:768-774.
7. Laxenaire MC, Moneret-Vautrin DA, Vervloet D: The French experience of anaphylactic reactions; in Sage D.I (ed): International Anesthesiology Clinics: Anaphylactoid Reactions in Anaesthesia. Boston. Little. Brown, 1985. pp 145-160.
8. Weiss ME, Adkinson NF Jr, Hirshnian CA: Evaluation of allergic drug reactions in the perioperative period. Anesthesiology 1989:71: 483-486.
9. Fisher MM. More DF.: The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaestli Intensive Care 1981:9: 226-234.
10. Fisher MM: The epidemiology of anaesthetic anaphylactoid reactions in Australasia. Klin Wochenschr 1982:60:1017-1020.
11. I i North FC. Kcltclkamp N. Hirshman CA: Comparison of cutaneous and in vitro histamine release by muscle relaxants. Anesthesiology 1987;66:543-546.
12. StcIlato C, de Paulis A, Cirillo R, Mastronardi P, Mazzarella B, Marone G: Heterogeneity of human mast cclls and basophils in response to muscle relaxants. Anesthesiology 1991:74: 1078-1086.
13. Stcllald C, Casolarid V, Ciccarelli A, Mastronardi P, Mazzarella B, Marone G: General anaesthetics induce only histamine release selectively from human mast cells. Br J Anaesth 1991; 67:751-758.
14. Moss J, Rosow CE, Savaresc JJ, Philbin DM, Kniffen KJ: Role of histamine in the hypotensive action of -tubocurarine in humans. Anesthesiology 1981:55:19-25.
15. Marone G. Giugliano R. Lembo G. Ayala F: Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol 1986:87:19 23.
16. Marone G. Casolaro V. Paganelli R. Quinti I: IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol 1989;93:246-252.
17. Vigorito C. Russo P. Picotti GB, Chiariello M. Poto S, Marone G: Effects of histamine infusion in man. J Cardiovasc Pharmacol 1983:5:531-537.
18. IS Vigorito C. Poto S. Picotti GB. Triggiani M. Marone G: Effects of activation of the H, receptor on coronary hemodynamics in man. Circulation 1986:73:1175-1182.
19. Vigorito C, Giordano A. De Caprio L, Vitale DF. Maurea N, Silvestri P. Tuccillo B. Ferrara N, Marone G. Rengo F: Effects of histamine on coronary hemodynamics in man: Role of II, and H. receptors. 1 Am Coll Cardiol 1987; 10: 1207 1213.
20. Marone G. Giordano A. Cirillo R. Triggiani M. Vigorito C: Cardiovascular and metabolic effects of peptide leukotrienes in man. Ann NY Acad Sci 1988:524:321 333.
21. Schrör K: Prostaglandin D - a potent coronary vasoconstrictor agent in the guinea-pig isolated heart. Naunyn Schmiedebergs Arch Pharmacol 1978:302:61-62.
22. Patella V. Marinò I. Lamparter B. Arbustini E. Adt M. Marone G: 1 luman heart mast cells. Isolation. purification, ultrastructure, and immunologic characterization. J Immunol 1995:154: 2855-2865.
23. Marone G. de Crescenzo G. Adt M. Patella V. Arbustini E. Genovese A: Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 1995:31:1-18.
24. Philbin DM. Moss J. Akins CW. Rosow CE. Ko-no K. Schneider RC. VerLce TR. Savarese JJ: The use of II, and H< antagonists with morphine anesthesia: A double-blind study. Anesthesiology 1981:55:292-296.
25. Tryba M. Zevounou F. Zcnz M: Prevention of histamine-induced reactions during the induction of anaesthesia following premedication with H- + 11.--antagonists i.m. Br J Anaesth 1986:58:478 482.
26. Lorenz W, Dick W, Jungingcr T, Ohmann C, Ennis M, Immich H, McPcek B, Dietz W, Weber D: Induction of anaesthesia and perioperative risk: Influence of antihistamine 11,- + H,-prophylaxis and volume substitution with I laemac-cel-35 on cardiovascular and respiratory disturbances and histamine release. Theor Surg 1988:3:55-77.
27. Fisher M. Baldo BA: Anaphylactoid reactions during anaesthesia. Clin Anaesth 1984:2:677-692.
28. Vervloct D. Amaud A. Senft M. Dor P. Bon-grand P. Charpin C. Alazia M: Leukocyte histamine release to suxamethonium in patients with adverse reactions to muscle relaxants. J Allergy Clin Immunol 1985:75:338 342.
29. Baldo BA. Fisher MM: Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983;306:262-264.
30. Harle DG. Baldo BA. Smal MA. Wajon P. Fisher MM: Detection of thiopentone-reactive IgE antibodies following anaphylactoid reactions during anaesthesia. Clin Allergy 1986:16:493 498.
31. Weiss ME, Nyhan D. Peng Z. Horrow JC, Low-enstein E. Hirshman C. Adkinson NF Jr: Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine. N Engl J Med 1989:320:886-892.
32. Harle DG, Baldo BA, Coroneos NJ, Fisher MM: Anaphylaxis following administration of papa-verctum: Case report. Implication of IgE antibodies that react w ith morphine and codeine, and identification of an allergenic determinant. Anesthesiology 1989:71:489-494.
33. Watkins J: Markers and mechanisms of anaphylactoid reactions: in Asscm (ed): Allergic Reactions to Anesthetics. Clinical and Basic Aspects. Basel. Karger. 1992. vol 30. pp 108-129.
34. Keith PK, Dolovich J: Anaphylactic and anaphylactoid reactions in the perioperative period. Immunol Allergy Clin North Am 1992:12:671-693.
35. Arroyave CM. Schatz M. Simon RA: Activation of the complement system by radiographic contrast media: Studies in vivo and in vitro. J Allergy Clin Immunol 1979;63:276-280.
36. Cogen FC. Norman ME. Dunsky E. Hirshfeld J. Zwciman B: Histamine release and complement changes following injection of contrast media in humans. J Allergy Clin Immunol 1979:64:299-303.
37. Schulman ES. Post TJ. Henson PM. Giclas PC: Differential effects of the complement peptides. C5a and C5a des Arg on human basophils and lung mast cells. J Clin Invest 1988;81:918-926.
38. Guldager H. Sondergaard I: Histamine release from basophil leukocytes in asthma patients after in vitro provocation with various neuromuscular blocking drugs and intravenous anaesthetic agents. Acta Anaesthesiol Scand 1987:31: 728 729.
39. Casolaro V. Galeone D. Giacummo A. Sanduzzi A. Mclillo G. Marone G: Human basophil/mast cell releasability. V. Functional comparisons of cclls obtained from peripheral blood, lung parenchyma and from bronchoalvcolar lavage in asthmatics. Am Rev Respir Dis 1989:139: 1375-1382.
40. Marone G. Triggiani M. Cirillo R. Giacummo A. Ilammarström S. Condorelli M: IgE-medi-ated activation of human heart in vitro. Agents Actions 1986;18:194-196.
41. Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM: Purification and characterization of human skin mast cells. Evidence for human mast cclls heterogeneity. J Immunol 1987:139:3062-3069.
42. Marone G, Casolaro V. Cirillo R, Condorelli M: Heterogeneity of human mast cclls and basophils. Ital J Med 1988:4:123-129.
43. Dvorak AM, Galli SI, Schulman ES, Lichten stein LM, Dvorak IIF: Basophil and mast cell degranulation: Ultrastructural analysis of mechanisms of mediator release. Fed Proc 1983;42:2510-2515.
44. Marone G, Casolaro V, Cirillo R, Stellato C, Genovese A: Pathophysiology of human basophils and mast cells in allergic disorders. Clin Immunol Immunopathol 1989:50:S24-S40.
45. Lowman MA. Rees PH. Benyon RC. Church MK: Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 1988:81:590-597.
46. Tharp MD, Kagey-Sobotka A, Fox CC, Marone G, Lichtenstein LM, Sullivan TJ: Functional heterogeneity of human mast cells from different anatomic sites: In vitro responses to morphine sulphate. J Allergy Clin Immunol 1987; 79:646-653.
47. Stellato C, Cirillo R. de Paulis A. Casolaro V, Patella V, Mastronardi P. Mazzarclla B. Marone G: Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology 1992:77: 932 940.
48. Lorenz W. Ennis M. Docnicke A. Dick W: Perioperative uses of histamine antagonists. J Clin Ancsth 1990;2:345-360.
49. Schwartz LB. Metcalfe DD, Miller JS. Earl H, Sullivan T: Tryptasc levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987:316: 1622 1626.
50. Laroche D. Vcrgnaud MC. Sillard B. Soufarapis II. Bricard H: Biochemical markers of anaphylactoid reactions to drugs. Anesthesiology 1991:75:945-949.
51. Didier A. Cador D. Bongrand P. Furstoss R. Fourneron P. Senft M. Philip-Joet D. Charpin D. Charpin J. Vervloct D: Role of the quaternary ammonium ion determinant in allergy to muscle relaxants. J Allergy Clin Immunol 1982:79: 578-584.
52. Docnicke A: Pscudo-allergic reactions due to histamine release during intravenous anaesthesia; in Dukor P (ed): Pseudo-Allergic Reactions. Involvements of Drugs and Chemicals. Basel. Karger. 1980. vol I. pp 224-250.
53. Marone G, Poto S, di Martino L, Condorelli M: Human basophil releasability. I. Age-related changes in basophil releasability. J Allergy Clin Immunol 1986:77:377-383.
54. Marone G, Polo S, Celestino D. Bonini S: I lu-man basophil rclcasability. III. Genetic control of human basophil rclcasability. J Immunol 1986:137:3588 3592.
55. Stcllato C, de Crescenzo G, Patella V, Mastro-nardi P, Mazzarella B, Marone G: Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release. J Allergy Clin Immunol 1996: in press.
56. Rowlands DE: Harmless cutaneous reactions associated with the use of atracurium: A report of 1,200 anaesthetics. Br J Anaesth 1987:59: 693-696.
57. Lorenz W, Doenicke A, Meyer R. Reimann HJ. Kusche J, Barth II, Gccsing H, Ilutzcl M, Wcis-senbaker li: Histamine release in man by propanidid and thiopentone: Pharmacological effects and clinical consequences. Br J Anaesth 1972: 44:355-368.
58. Hirshman CA, Peters J, Cartwright-Lee I: Leukocyte histamine release to thiopental. Anesthesiology 1982;56:64-67.
59. Briggs I.P. Clarke RSJ. Watkins J: An adverse reaction to the administration ofdisoprofol 'Di-privan. Anaesthesia 1982;37:1099-1101.
60. Doenicke A. Lorenz W, Stanworth D. Duka T, Glen GB: Effects of propofol (‘Diprivan’) on histamine release, immunoglobulin levels and activation of complement in healthy volunteers. Postgrad Med J 1985;61(suppl 3): 15-20.
61. Hirshman CA, Edelstein RA, Ebertz JM, Han-ifin JM: Thiobarbiturate-induced histamine release in human skin mast cells. Anesthesiology 1985;63:353-356.
62. Davison TC: Intravenous anesthesia in modern surgery (sodium-pentothal-oxygen). Curr Res Anaesth Analg 1943;22:52-56.
63. Mathieu A, Goudsotizian N, Snider MT: Reaction to ketamine: Anaphylactic or anaphylactoid? Br J Anaesth 1975:47:624-627.
64. Rosow CE, Moss J, Philbin DM, Savaresc JJ: I listamine release during morphine and fcnta-nyl anesthesia. Ancstesiology 1982;56:93-96.
65. Moss J, Rosow CE: Histamine release by narcotics and muscle relaxants in humans. Anesthesiology 1983:59:330-339.
66. Fisher MM. Harle DG. Baldo BA: Anaphylactoid reactions to narcotic analgesics. Clin Rev Allergy 1991;9:309-318.
67. Benyon RC. Robinson C. Church MK: Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and lion-immunological stimuli. Br J Pharmacol 1989:97:898-904.
68. Philbin DM. Moss J. Rosow CE. Akins CW. Rosenberger JL: Histamine release with intravenous narcotics: Protective effects of 1L- and 1L-receptor antagonists. Klin Wochenschr 1982;60:1056-1059.
69. Schwartz LB, Yunginger JW, Miller I, Bokhari R, Dull D: Time coursc of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989:83:1551 1555.
70. Jaffc JH, Martin WR: Opioid analgesics and antagonists; in Goodman-Gilman A, Goodman LS, Rail TW, Murad F (cds): The Pharmacological Basis of Therapeutics. New York. Pergamon Press, 1990, pp 485-521.
71. Levy JH, Brisler NW, Shcarin A, Ziegler J, Hug CC, Adclson DM, Walker BF: Wheal and flare responses to opioids in humans. Anesthesiology 1989:70:756 760.
72. Zucker-Pinchofif B, Ramanathan S: Anaphylactic reaction to epidural fentanyl. Anesthesiology 1989;71:599-601.
73. Reves JG: Benzodiazepines; in Prys-Roberts C. Hug CC Jr (cds): Pharmacokinetics of Anaesthesia. Oxford. Blackwell Scientific Publications. 1984. pp 157-185.
74. Laxenaire MC, Borgo J, Menu N, Holzer J, Royer R: Evolution de I’histamine plasmalique après midazolam chez les sujes à risque d'hista-minolibération. Ann Fr Anesth Réanim 1985:4: 238-240.
75. Reves JG, Satnuelson PN, Lewis S: Midazolam maleate induction in patients with ischaemic heart disease: Haemodynamic observations. Can Anaesth Soc.1 1979:26:402 409.
76. Samuelson PN, Reves JG. Kouchoukos NT. Smith IR, Dole KM: Hemodynamic responses to anesthetic induction with midazolam or diazepam in patients with ischemic heart disease. Anesth Analg 1981:60:802-809.
77. Licberman P: Anaphylactoid reactions to radiocontrast material. Immunol Allergy Clin North Am 1992:3:649-670.
78. Erflmcycr JE, Siegle RL, Licbcrman P: Anaphylactoid reactions to radiocontrast material. J Allergy Clin Immunol 1985:75:401-410.
79. Bush WH. Swanson D: Acute reactions to in-travascular contrast media: Types, risk factors, recognition, and specific treatment. AJR 1991; 157:1153-1161.
80. Grecnbcrger PA: Contrast media reactions. J Allergy Clin Immunol 1984:74:600-605.
81. Grecnbcrger PA. Patterson R: The prevention of immediate generalized reactions contrast media in high-risk patients. J Allergy Clin Immunol 1991:87:867-872.
82. Bielory L. Kaliner MA: Anaphylactoid reactions to radiocontrast materials. Int Anesthesiol Clin 1985;3:97-118.
83. Simon RA, Schatz M, Stevenson DD, Curry C, Yamamoto F, Plow E, Ring J, Arroyave C: Radiographic contrast media infusions. Measurement of histamine, complement, and fibrin split products and corrélation with clinical parameters. J Allergy Clin Immunol 1979;63:281-288.
84. Kaliner M, Dyer J, Merlin S, Shelton A, Grcen-hill A, Treadwell G, McKenna W, Lieberman P: Increased urine histamine and contrast media reactions. Invest Radiol 1984:2:116-118.
85. Ennis M, Lorenz W, Nchring E, Schneider C: In vitro and in vivo studies of radiographic contrast media-induced histamine release in pigs. Agents Actions 1991;33:26-29.
86. Assem ESK. Bray K: The release of histamine from human basophils by radiological contrast agents. Br J Radiol 1983:56:647-652.
87. Salem DN, Findlay SR, Isncr JM, Konstant MA, Cohen PF: Comparison of histamine release effects of ionic and non-ionic radio-graphic contrast media. Am J Med 1986:80: 382-384.
88. Anton EU, Ennis M, Lorenz W, Schnabel M, Schneidert S: Histamine release induced by radiographic contrast media. Comparison between pulmonary and peritoneal mast cells derived from normotensive and spontaneously hypertensive rats. Int Arch Allergy Appl Immunol 1990;92:203-208.
89. Eggleston PA, Kagcy-Sobotka A, Lichtenstein LM: A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Rcspir Dis 1987:135:1043- 1048.
90. Findlay SR. Dvorak AM. Kagey-Sobotka A. Lichtenstein LVI: Hyperosmolar triggering of histamine release from human basophils. J Clin Invest 1981;67:1604-1613.
91. Adt M, Patella V, Marino I, Lamparter B, Marone G: Immunologic characterization of human heart mast cclls. J Invest Dermatol 1994: 103:621.
92. Anscii G, Tweedie MCK, West CR, Evans P: Risk factors for adverse reactions in intravenous urography; in Amiel M (ed): Contrast Media in Radiology. Berlin. Springer, 1982. pp 7-10.
93. McGovern VJ: Mast cells and their relationship to endothelial surfaces. J Pathol Bacteriol 1956:71:1-6.
94. Pcpler WJ. Meyer BJ: Mast cells in the coronary arteries. A comparative study of South African Bantu and European hearts. Arch Pathol 1961;71:103-107.
95. Femex M: The Mast-Cell System. Its Relationship to Atherosclerosis. Fibrosis and Eosinophils. Baltimore. Williams & Wilkins, 1968.
96. Estensen RD: Eosinophilic myocarditis: A role for mast cells? Arch Pathol Lab Med 1984: 108:358-359.
97. Forman MB, Oates JA, Robertson D, Robertson RM, Roberts LJ, Virmani R: Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 1985;313:1138-1141.
98. Dvorak AM: Mast-cell degranulation in human hearts. N Engl J Med 1986;315:969-970.
99. Marone G, Triggiani M, Cirillo R, Giacummo A, Ilammarstrom S. Condorelli M: IgE-medi-atcd activation of human heart in vitro. Agents Actions 1986:18:194 196.
100. Assent ESK. Ghanem NS: Demonstration of IgE-sensitized mast cells in human heart and kidney. Int Arch Allergy Appl Immunol 1988; 87:10t-104.
101. Kaartinen M, Penttila A, Kovanen PT: Accumulation of activated mast cclls in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994;90:1669-1678.
102. Olin T: Adverse reactions to intravascularly administered contrast media. Acta Radiol 1986:27:257 263.